Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Suzette Oelofse
Development of a human respiratory tract effector cell-mediated antiviral assay using blood and airway immune cells from individuals previously hospitalised with COVID-19
Abstract Serum antibody–based neutralisation assays correlate with protective immunity to SARS-CoV-2, but cell-mediated in vitro cytotoxicity assays are lacking. Data on virus-specific respiratory tract immune responses in humans remain limited. Fifteen healthy participants who had previously been hospitalised with severe COVID-19 pneumonia were recruited. Peripheral blood mononuclear cells (PBMCs), bronchoalveolar lavage (BAL), and nasal lavage (NL) cells were phenotyped by flow cytometry.
Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa
Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa http://orcid.org/0000-0002-4672-0500Nitika Pai1,2, Aliasgar Esmail3,4, Paramita Saha Chaudhuri5, Suzette Oelofse4, Marietjie Pretorius4, Gayatri Marathe5, Jana Daher2, Megan Smallwood2,5, Nicolaos Karatzas6, Mohammed Fadul4, Anna de Waal2,5, Nora Engel7, Alice Anne Zwerling8, Keertan Dheda3,4,9 1 Department of Medicine, McGill University, Montreal,...
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa Olatunde Olayanju, Jason Limberis, Aliasgar Esmail, Suzette Oelofse, Phindile Gina, Elize Pietersen, Mohammed Fadul, Rob Warren, Keertan Dheda European Respiratory Journal May 2018, 51 (5) 1800544; DOI: 10.1183/13993003.00544-2018
LONG TERM BEDAQUILINE-RELATED TREATMENT OUTCOMES IN PATIENTS WITH EXTENSIVELY DRUG RESISTANT TUBERCULOSIS FROM SOUTH AFRICA
ExtractOptimal treatment regimens for patients with extensively drug-resistant TB (XDR-TB) remain unclear. Long-term prospective outcome data comparing XDR-TB regimens, with and without bedaquiline (Bdq), from an endemic setting are lacking.We prospectively followed up 272 South African patients (49.3% HIV-infected; median CD4 169 cells/µl) with newly diagnosed XDR-TB between 2008 and 2017.
LONG TERM BEDAQUILINE-RELATED TREATMENT OUTCOMES IN PATIENTS WITH EXTENSIVELY DRUG RESISTANT TUBERCULOSIS FROM SOUTH AFRICA
ExtractThe persistence of the multi-drug-resistant tuberculosis (MDR-TB) epidemic threatens to destabilise TB control [1, 2]. MDR-TB is defined as a TB strain with resistance to at least isoniazid and rifampicin. In 2016 ∼600 000 new cases of MDR- or rifampicin-resistant TB were estimated to have occurred globally.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Suzette
Contact Suzette, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack